Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 91

Sort by

Sort Order Select

Journal Articles

Dynamics of Immune Reconstitution in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Matched Sibling Donor Stem Cell Transplantation: A Conventional and Computational Analysis

Elisabeth Dovern, Tim R. Mocking, Mette D. Hazenberg, Arjan A. van de Loosdrecht, Simon Tol, Erik Mul, Boukje M. Beuger, Robin van Bruggen, Myrddin Verheij, Carlijn Voermans, Costa Bachas, Bart J. Biemond, Erfan Nur

Blood (2024) 144 (Supplement 1): 3527.

https://doi.org/10.1182/blood-2024-194366

Published: 2024

Journal Articles

Iron Deficiency in HbSC Disease Is Associated with Less Sickle Cell Disease-Related Complications - a Rationale for Repetitive Phlebotomy As Disease Modifying Therapy

Marissa J.M. Traets, Aida Kidane, Jennifer Bos, Brigitte A. van Oirschot, Sigrid van der Veen, Mandy N. Lauw, Erfan Nur, Bart J. Biemond, Marjon H. Cnossen, Eduard J. Van Beers, Richard van Wijk, Minke A.E. Rab

Blood (2024) 144 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2024-204666

Published: 2024

Journal Articles

Artificial-Intelligence Driven Quantification of Sickle Red Blood Cell Morphology As an Objective Disease Marker

Lydian A. De Ligt, Eelke Brandsma, Aafke E. Gaartman, Guusje Van Gameren, Colin Blans, Martijn Veldthuis, Hanke Matlung, Bart J. Biemond, Erfan Nur, Emile Van Den Akker, Robin van Bruggen

Blood (2024) 144 (Supplement 1): 4996.

https://doi.org/10.1182/blood-2024-199994

Published: 2024

Journal Articles

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Blood (2024) 144 (Supplement 1): 290.

https://doi.org/10.1182/blood-2024-200639

Published: 2024

Journal Articles

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Blood (2024) 144 (Supplement 1): 1250.

https://doi.org/10.1182/blood-2024-201997

Published: 2024

Journal Articles

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 1138.

https://doi.org/10.1182/blood-2024-203331

Published: 2024

Journal Articles

Alterations in the Immune Phenotype of Adaptive Immune Cells in Sickle Cell Disease: A Conventional and Computational Flow Cytometry Analysis

Elisabeth Dovern, Tim R. Mocking, Mette D. Hazenberg, Cornelis R van der Torren, Boukje M. Beuger, Robin van Bruggen, Simon Tol, Erik Mul, Marjolein van der Pot, Arjan A. van de Loosdrecht, Myrddin Verheij, Karin Fijnvandraat, Carlijn Voermans, Bart J. Biemond, Costa Bachas, Erfan Nur

Blood (2024) 144 (Supplement 1): 2483.

https://doi.org/10.1182/blood-2024-194363

Published: 2024

Journal Articles

The Pulmonary Embolism Rule-out Criteria (PERC) to Rule out Acute Pulmonary Embolism in Patients with Sickle Cell Disease: A Retrospective Cohort Study

Sanjay R. Thakoerdin, Chanel C. de Ruiter, Aafke Gaartman, Nick Van Es, Bart J. Biemond, Erfan Nur

Blood (2024) 144 (Supplement 1): 2507.

https://doi.org/10.1182/blood-2024-203157

Published: 2024

Journal Articles

Assessment of Neurocognitive Functioning in Sickle Cell Disease and Thalassemia and the Association with Silent Cerebral Infarcts and Cerebral Hemodynamics and Oxygen Metabolism

Liza Afzali-Hashemi, Melanie Franse, Koen P.A. Baas, Anouk Schrantee, John C. Wood, Aart J Nederveen, Bart J. Biemond, Sharon O'Neil

Blood (2023) 142 (Supplement 1): 1153.

https://doi.org/10.1182/blood-2023-189194

Published: 2023

Journal Articles

Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis

Lydian A. de Ligt, Aafke E. Gaartman, Kadère Konté, Taco W. Kuijpers, Karin Fijnvandraat, Bart J. Biemond, Robin van Bruggen, Erfan Nur

Blood (2023) 142 (Supplement 1): 1108.

https://doi.org/10.1182/blood-2023-179239

Published: 2023

Journal Articles

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

Myrthe J. van Dijk, Minke A.E. Rab, Brigitte A. van Oirschot, Jennifer Bos, Cleo Derichs, Anita W. Rijneveld, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Marije Bartels, Judith J.M. Jans, Wouter W. van Solinge, Roger E.G. Schutgens, Richard van Wijk, Eduard J. Van Beers

Blood (2023) 142 (Supplement 1): 2515.

https://doi.org/10.1182/blood-2023-172829

Published: 2023

Journal Articles

The Effect of Voxelotor on Erythrocyte Deformability, Neutrophil Phenotype and Endothelial Activation

Kadère Konté, Aafke E. Gaartman, Isha Tanwar, Boukje Beuger, Martijn Veldthuis, Rob Van Zwieten, Robin van Bruggen, Bart J. Biemond, Erfan Nur

Blood (2023) 142 (Supplement 1): 3872.

https://doi.org/10.1182/blood-2023-185822

Published: 2023

Journal Articles

The Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Sickle Cell Disease-Related Organ Damage: A Systematic Review and Meta-Analysis

Elisabeth Dovern, Mesire Aydin, Komeil Alizade, Bart J. Biemond, Erfan Nur

Blood (2023) 142 (Supplement 1): 2364.

https://doi.org/10.1182/blood-2023-174436

Published: 2023

Journal Articles

A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse with Improved Prognostic Accuracy

Niek G. Van Der Maas, Dimitri Breems, Clara Klerk, Thomas Pabst, Patrycja Gradowska, Bart J. Biemond, Jurgen Kuball, Janine Van Elssen, Otto Visser, Marie-Christiane Vekemans, Carlos Graux, Johan Maertens, H. Berna Beverloo, Peter J. M. Valk, Gert J. Ossenkoppele, Bob Lowenberg, Geert A. Huls, Jan J. Cornelissen, Jurjen Versluis

Blood (2023) 142 (Supplement 1): 724.

https://doi.org/10.1182/blood-2023-180812

Published: 2023

Journal Articles

Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease

Marissa J.M. Traets, Sigrid van der Veen, Jennifer Bos, Laura van Pelt, Aida Kidane, Brigitte A. van Oirschot, Wouter W. van Solinge, Saskia Schols, Mandy N. Lauw, Marjon H. Cnossen, Erfan Nur, Bart J. Biemond, Eduard J. Van Beers, Anita W. Rijneveld, Richard van Wijk, Minke A.E. Rab

Blood (2023) 142 (Supplement 1): 561.

https://doi.org/10.1182/blood-2023-180755

Published: 2023

Journal Articles

Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial

Maureen Okam Achebe, Hoda MA Hassab, Salam Al-Kindi, Clark Brown, Paul Telfer, Bart J. Biemond, Thokozeni Lipato, Mark Davis, Sarah Gray, Victor R. Gordeuk

Blood (2023) 142 (Supplement 1): 2527.

https://doi.org/10.1182/blood-2023-188616

Published: 2023

Journal Articles

Analysis of Volatile Organic Compounds in Exhaled Air in Patients with Sickle Cell Disease during Vaso-Occlusive Episodes

Caroline Vuong, Paul Brinkman, Harriët Heijboer, Erfan Nur, Cornelia De Groot - Eckhardt, Suzanne W.J. Terheggen-Lagro, Bart J. Biemond, Anke-Hilse Maitland-van der Zee, Karin Fijnvandraat

Blood (2023) 142 (Supplement 1): 1131.

https://doi.org/10.1182/blood-2023-180835

Published: 2023

Journal Articles

Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study

Man Wai Tang, Deborah van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A. van de Loosdrecht, Ellen Meijer, Caroline E. Rutten, Marielle Wondergem, Jeroen J.W.M. Janssen, Marjolein Donker, Mette D. Hazenberg, Sonja Zweegman, Bart J. Biemond, David C. de Leeuw, Erfan Nur

Blood (2022) 140 (Supplement 1): 3287–3289.

https://doi.org/10.1182/blood-2022-163042

Published: 2022

Journal Articles

The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine

Sjoerd J.F. Hermans, Yvette Norden, Jurjen Versluis, Anita W. Rijneveld, Okke De Weerdt, Bart J. Biemond, Arjan A. van de Loosdrecht, Lotte E. Van der Wagen, Mar Bellido, Michel Van Gelder, Walter J.F.M. Van der Velden, Dominik Selleslag, Danielle van Lammeren, Vincent H.J. van der Velden, Liesbeth C. de Wreede, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen

Blood (2022) 140 (Supplement 1): 8890–8892.

https://doi.org/10.1182/blood-2022-163055

Published: 2022

Journal Articles

Cerebral Oxygen Metabolism in Patients with Mild and Severe Sickle Cell Disease and Thalassemia

Liza Afzali-Hashemi, Koen P.A. Baas, Anouk Schrantee, Erfan Nur, John C Wood, Aart J. Nederveen, Bart J. Biemond

Blood (2022) 140 (Supplement 1): 8258–8259.

https://doi.org/10.1182/blood-2022-168736

Published: 2022

NARROW

Dynamics of Immune Reconstitution in Adults with Sickle Cell Disease Undergoing Nonmyeloablative Matched Sibling Donor Stem Cell Transplantation: A Conventional and Computational Analysis

Iron Deficiency in HbSC Disease Is Associated with Less Sickle Cell Disease-Related Complications - a Rationale for Repetitive Phlebotomy As Disease Modifying Therapy

Artificial-Intelligence Driven Quantification of Sickle Red Blood Cell Morphology As an Objective Disease Marker

Oxygen Gradient Ektacytometry Is Associated with Markers of Hemolysis and Inflammation in a Large Sickle Cell Disease Cohort within the GenoMed4ALL Project

Derivation and External Validation of a Venous Thromboembolism Risk Prediction Model in Patients with Acute Lymphoblastic Leukemia Receiving Asparaginase Therapy

Data Driven Research through the European RADeep Registry and the Use of Artificial Intelligence Towards Personalized Medicine in Sickle Cell Disease

Alterations in the Immune Phenotype of Adaptive Immune Cells in Sickle Cell Disease: A Conventional and Computational Flow Cytometry Analysis

The Pulmonary Embolism Rule-out Criteria (PERC) to Rule out Acute Pulmonary Embolism in Patients with Sickle Cell Disease: A Retrospective Cohort Study

Assessment of Neurocognitive Functioning in Sickle Cell Disease and Thalassemia and the Association with Silent Cerebral Infarcts and Cerebral Hemodynamics and Oxygen Metabolism

Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis

One-Year Safety and Efficacy of Mitapivat in Sickle Cell Disease: Follow-up Results of a Phase 2, Open-Label Study

The Effect of Voxelotor on Erythrocyte Deformability, Neutrophil Phenotype and Endothelial Activation

The Effect of Allogeneic Hematopoietic Stem Cell Transplantation on Sickle Cell Disease-Related Organ Damage: A Systematic Review and Meta-Analysis

A Novel Prognostic Model for Patients with Acute Myeloid Leukemia in First Relapse with Improved Prognostic Accuracy

Pyruvate Kinase Thermostability Is Associated with Red Blood Cell Adhesion, Deformability and Oxygen Affinity in Patients with Sickle Cell Disease

Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE Trial

Analysis of Volatile Organic Compounds in Exhaled Air in Patients with Sickle Cell Disease during Vaso-Occlusive Episodes

Comparison of Hidac Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Retrospective Study

The HOVON 100 Study in Adult Acute Lymphoblastic Leukemia Re-Analysed By Multi-State Modeling: Benefits and Risks of Clofarabine

Cerebral Oxygen Metabolism in Patients with Mild and Severe Sickle Cell Disease and Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only